Hitgen

A covalent fragment-based strategy targeting a novel cysteine to inhibit activity of mutant EGFR kinase

A covalent fragment-based strategy targeting a novel cysteine to inhibit activity of mutant EGFR kinase

Kuki, N. et al., RSC Med. Chem., 2023, 14, 2731-2737

< Back to all news
Would you like to learn more?

For further information about partnering with Vernalis, or to find out more about our capabilities or career opportunities.

bd@vernalis.com hr@vernalis.com
Contact us

Services

© 2024 Vernalis (R&D) Limited. All Rights Reserved. Web Design by Red Graphic. Web Development by Red Web.